The weekly litigation news digest is live. Subscribe now

IP Verse

A Pharmaceutical Composition Comprising Racecadotril And Process For Preparing The Same

Patent No. EP3592333 (titled "A Pharmaceutical Composition Comprising Racecadotril And Process For Preparing The Same") was filed by Athena Pharmaceutiques on Feb 20, 2018. The application was issued on Apr 3, 2024.

Patent Summary

UPC Cases New

Latest UPC cases involving this patent.

Case Number	Filing Date	Plaintiff	Proceeding Type
UPC_CFI_0000927/2025	Sep 25, 2025	LA Siddhi Consultancy	Revocation

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Feb 7, 2025
Communication regarding the expiry of opposition period
Apr 16, 2024
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Mar 7, 2024
Decision to grant a European patent
Feb 7, 2024
(Electronic) Receipt
Feb 7, 2024
French translation of claims
Feb 7, 2024
German translation of the claims
Feb 7, 2024
Letter accompanying subsequently filed items
Feb 1, 2024
Annex to the communication about intention to grant a European patent
Feb 1, 2024
Bibliographic data of the European patent application
Feb 1, 2024
Communication about intention to grant a European patent
Feb 1, 2024
Intention to grant (signatures)
Feb 1, 2024
Text intended for grant (clean copy)
Feb 1, 2024
Text intended for grant (version for approval)
Oct 31, 2023
(Electronic) Receipt
Oct 31, 2023
Amended claims with annotations
Oct 31, 2023
Claims
Oct 31, 2023
Letter accompanying subsequently filed items
Oct 31, 2023
Reply to communication from the Examining Division
Oct 18, 2023
Annex to the communication
Oct 18, 2023
Communication from the Examining Division
Jul 17, 2023
(Electronic) Receipt
Jul 17, 2023
Amended claims with annotations
Jul 17, 2023
Amended description with annotations
Jul 17, 2023
Claims
Jul 17, 2023
Description
Jul 17, 2023
Letter accompanying subsequently filed items
Jul 17, 2023
Reply to communication from the Examining Division
May 16, 2023
Annex to the communication
May 16, 2023
Communication from the Examining Division
Sep 21, 2022
(Electronic) Receipt
Sep 21, 2022
Amended description with annotations
Sep 21, 2022
Description
Sep 21, 2022
Letter accompanying subsequently filed items
Sep 21, 2022
Reply to communication from the Examining Division
Jul 21, 2022
Annex to the communication
Jul 21, 2022
Communication from the Examining Division
Jul 26, 2021
(Electronic) Receipt
Jul 26, 2021
Amended claims with annotations
Jul 26, 2021
Claims
Jul 26, 2021
Letter accompanying subsequently filed items
Jul 26, 2021
Reply to communication from the Examining Division
May 3, 2021
Annex to the communication
May 3, 2021
Communication from the Examining Division
Apr 23, 2021
Examination started
Feb 17, 2021
(Electronic) Receipt
Feb 17, 2021
Letter accompanying subsequently filed items
Feb 17, 2021
Statement of non-availability of priority search results
Feb 3, 2021
Invitation to file a copy of search results(priority)
Feb 2, 2021
Communication of amended entries concerning the representative
Jan 27, 2021
(Electronic) Receipt
Jan 27, 2021
Letter accompanying subsequently filed items
Jan 27, 2021
Non-patent literature cited during the examination procedure
Jan 27, 2021
Reply to Written Opinion prepared by the EPO
Jan 27, 2021
Submission concerning change of applicant's representative
Aug 7, 2020
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jul 21, 2020
Communication regarding the transmission of the European search report
Jul 21, 2020
European search opinion
Jul 21, 2020
Information on Search Strategy
Jul 21, 2020
Supplementary European search report
Jul 9, 2020
Search started
Mar 9, 2020
Communication of the registration of a transfer or change of name and/or address
Feb 28, 2020
(Electronic) Receipt
Feb 28, 2020
Annexes in respect of a client data request
Feb 28, 2020
Letter accompanying subsequently filed items
Feb 28, 2020
Submission concerning a transfer of rights (applicant)
Dec 18, 2019
Notification on forthcoming publication of bibliographic data
Oct 15, 2019
Communication regarding possible amendment of the application/payment of claims fee
Oct 11, 2019
Communication to designated inventor
Oct 11, 2019
Communication to designated inventor
Oct 11, 2019
Communication to designated inventor
Oct 1, 2019
Copy of the international preliminary report on patentability
Jan 30, 2019
(Electronic) Receipt
Jan 30, 2019
Authorisation
Jan 30, 2019
Letter accompanying subsequently filed items
Jan 30, 2019
Submission concerning representation
Nov 23, 2018
Information regarding early processing
Nov 7, 2018
(Electronic) Receipt
Nov 7, 2018
Request for entry into the European phase
Oct 9, 2018
Notification of the recording of a change
Oct 3, 2018
Priority document (electronically transmitted)
Sep 13, 2018
Copy of the international search report
Sep 13, 2018
Published international application - A1

EP3592333

ATHENA PHARMACEUTIQUES

Application Number: EP18763649A
Filing Date: Feb 20, 2018
Status: No Opposition Filed Within Time Limit; Feb 7, 2025
Publication Date: Apr 3, 2024
External Links: Slate, EP3592333B1, Google Patents